File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Low-dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma

TitleLow-dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma
Authors
Keywordshodgkin lymphoma
PD-1
pembrolizumab
refractory
Issue Date2017
Citation
British Journal of Haematology, 2017, v. 176 n. 1, p. 131-132 How to Cite?
DescriptionLink to Free access
Persistent Identifierhttp://hdl.handle.net/10722/227221
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorKwong, YL-
dc.contributor.authorLopes, D-
dc.contributor.authorKhong, PL-
dc.date.accessioned2016-07-18T09:09:10Z-
dc.date.available2016-07-18T09:09:10Z-
dc.date.issued2017-
dc.identifier.citationBritish Journal of Haematology, 2017, v. 176 n. 1, p. 131-132-
dc.identifier.urihttp://hdl.handle.net/10722/227221-
dc.descriptionLink to Free access-
dc.languageeng-
dc.relation.ispartofBritish Journal of Haematology-
dc.subjecthodgkin lymphoma-
dc.subjectPD-1-
dc.subjectpembrolizumab-
dc.subjectrefractory-
dc.titleLow-dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma-
dc.typeArticle-
dc.identifier.emailKwong, YL: ylkwong@hkucc.hku.hk-
dc.identifier.emailKhong, PL: plkhong@hku.hk-
dc.identifier.authorityKwong, YL=rp00358-
dc.identifier.authorityKhong, PL=rp00467-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/bjh.13920-
dc.identifier.scopuseid_2-s2.0-85006745134-
dc.identifier.hkuros258991-
dc.identifier.volume176-
dc.identifier.issue1-
dc.identifier.spage131-
dc.identifier.epage132-
dc.identifier.isiWOS:000393611900016-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats